173 related articles for article (PubMed ID: 38113227)
1. Menopausal hormone therapy and central nervous system tumors: Danish nested case-control study.
Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
PLoS Med; 2023 Dec; 20(12):e1004321. PubMed ID: 38113227
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis.
Benson VS; Kirichek O; Beral V; Green J
Int J Cancer; 2015 May; 136(10):2369-77. PubMed ID: 25335165
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system tumours among users of vaginal oestradiol tablets: A nationwide population-based study.
Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
Eur J Neurol; 2023 Sep; 30(9):2811-2820. PubMed ID: 37309803
[TBL] [Abstract][Full Text] [Related]
4. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E
Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638
[TBL] [Abstract][Full Text] [Related]
5. Association of Hormone Therapy With Depression During Menopause in a Cohort of Danish Women.
Wium-Andersen MK; Jørgensen TSH; Halvorsen AH; Hartsteen BH; Jørgensen MB; Osler M
JAMA Netw Open; 2022 Nov; 5(11):e2239491. PubMed ID: 36318208
[TBL] [Abstract][Full Text] [Related]
6. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.
Schairer C; Lubin J; Troisi R; Sturgeon S; Brinton L; Hoover R
JAMA; 2000 Jan; 283(4):485-91. PubMed ID: 10659874
[TBL] [Abstract][Full Text] [Related]
7. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E
Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818
[TBL] [Abstract][Full Text] [Related]
10. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-progestin replacement therapy and endometrial cancer.
Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
[TBL] [Abstract][Full Text] [Related]
12. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
[TBL] [Abstract][Full Text] [Related]
13. Tumors of the central nervous system among women treated with fertility drugs: a population-based cohort study.
Frandsen CLB; Jensen A; Poulsen FR; Møller M; Lindquist S; Albieri V; Nøhr B; Kjær SK
Cancer Causes Control; 2022 Oct; 33(10):1285-1293. PubMed ID: 35895242
[TBL] [Abstract][Full Text] [Related]
14. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
15. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
16. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
[TBL] [Abstract][Full Text] [Related]
17. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.
Custer B; Longstreth WT; Phillips LE; Koepsell TD; Van Belle G
BMC Cancer; 2006 Jun; 6():152. PubMed ID: 16759391
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
19. Association Between Maternal Hormonal Contraception Use and Central Nervous System Tumors in Children.
Hargreave M; Mørch LS; Winther JF; Schmiegelow K; Kjaer SK
JAMA; 2022 Jan; 327(1):59-66. PubMed ID: 34982120
[TBL] [Abstract][Full Text] [Related]
20. Menopausal hormone replacement therapy and risk of ovarian cancer.
Lacey JV; Mink PJ; Lubin JH; Sherman ME; Troisi R; Hartge P; Schatzkin A; Schairer C
JAMA; 2002 Jul; 288(3):334-41. PubMed ID: 12117398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
